AUERBACH ALAN H (PRESIDENT AND CEO) sold 0.5% of their position (34.95K shares) of PUMA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $204.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/8/2026ACC: 0001437749-26-000924
DirectorOfficer10% Owner· PRESIDENT AND CEO
Since Jul 2018
-34.95K
Net shares
Net seller
$204.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
34.95K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−16.94K
Price / share
$5.84
Trade value
$98.99K
% of position
0.2%
1/6/2026
7.18M→7.16M
Common Stock
Direct
Shares
−18.01K
Price / share
$5.88
Trade value
$105.89K
% of position
0.3%
1/7/2026
7.16M→7.15M
Total
Net shares
−34.95K
Net value
-$204.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2026 | S · Sale | −16.94K | $5.84 | $98.99K | 0.2% | 7.18M | 7.16M |
| Common Stock Direct | 1/7/2026 | S · Sale | −18.01K | $5.88 | $105.89K | 0.3% | 7.16M | 7.15M |
| Total | −34.95K | -$204.88K | ||||||
Derivative Transactions0
No derivative transactions reported